Cargando…
Pectolinarigenin inhibits bladder urothelial carcinoma cell proliferation by regulating DNA damage/autophagy pathways
Pectolinarigenin (PEC), an active compound isolated from traditional herbal medicine, has shown potential anti-tumor properties against various types of cancer cells. However, its mechanism of action in bladder cancer (BLCA), which is one of the fatal human carcinomas, remains unexplored. In this st...
Autores principales: | Deng, Zhao, Shen, Dexin, Yu, Mengxue, Zhou, Fenfang, Shan, Danni, Fang, Yayun, Jin, Wan, Qian, Kaiyu, Li, Shenjuan, Wang, Gang, Zhang, Yi, Ju, Lingao, Xiao, Yu, Wang, Xinghuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314945/ https://www.ncbi.nlm.nih.gov/pubmed/37393350 http://dx.doi.org/10.1038/s41420-023-01508-9 |
Ejemplares similares
-
The inhibitory effect of silencing CDCA3 on migration and proliferation in bladder urothelial carcinoma
por: Shen, Dexin, et al.
Publicado: (2021) -
Melatonin inhibits bladder tumorigenesis by suppressing PPARγ/ENO1-mediated glycolysis
por: Shen, Dexin, et al.
Publicado: (2023) -
E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability
por: Xu, Huimin, et al.
Publicado: (2021) -
Immune‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer
por: Wang, Yejinpeng, et al.
Publicado: (2020) -
The inhibitory effect of melatonin on human prostate cancer
por: Shen, Dexin, et al.
Publicado: (2021)